Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$789.9K
4 trades · 1 insiders
Net · 90d
$-789.9K
Insiders on file
12
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Zhang Zhongwei | Director | 1 | $0 | $0 | 2026-10-07 |
| Sun Nelson | See Remarks | 11 | $251.6K | $789.9K | 2026-09-11 |
| Tong Victor Edward Jr | Director | 3 | $0 | $0 | 2026-08-14 |
| Chi Jeffrey | Director | 5 | $0 | $0 | 2026-08-14 |
| Baynes Roy D. | Director | 3 | $0 | $0 | 2026-08-14 |
| Graf Susan E | Director | 3 | $0 | $0 | 2026-08-14 |
| Jaiman Manasi | Chief Medical Officer | 2 | $0 | $0 | 2026-02-09 |
| Lee Tien-Li | Chief Executive Officer | 15 | $623.3K | $0 | 2026-02-09 |
| Jones Bryan | Chief Operating Officer | 3 | $0 | $0 | 2025-10-15 |
| Vickers Venture Fund VI Pte Ltd | 10% Owner | 4 | $0 | $0 | 2025-02-14 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | 6 | $20.00M | $0 | 2025-02-14 |
| Chen Bihua | Other | 3 | $3.00M | $0 | 2025-02-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Zhang Zhongwei | Director | A Award deriv | 2026-10-07 | 2026-10-08 | 127,061 | — | $0 | 127,061 | SEC↗ |
| Sun Nelson | See Remarks | S Sale | 2026-09-11 | 2026-09-11 | 62,000 | $5.18 | $321.2K | 35,475 | SEC↗ |
| Sun Nelson | See Remarks | S Sale | 2026-09-11 | 2026-09-11 | 62,000 | $5.18 | $321.2K | 35,475 | SEC↗ |
| Sun Nelson | See Remarks | S Sale | 2026-09-10 | 2026-09-11 | 14,754 | $5.00 | $73.8K | 97,475 | SEC↗ |
| Sun Nelson | See Remarks | S Sale | 2026-09-10 | 2026-09-11 | 14,754 | $5.00 | $73.8K | 97,475 | SEC↗ |
| Tong Victor Edward Jr | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Graf Susan E | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Chi Jeffrey | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Chi Jeffrey | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Graf Susan E | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Tong Victor Edward Jr | Director | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| Jaiman Manasi | Chief Medical Officer | A Award deriv | 2026-02-09 | 2026-02-11 | 70,549 | — | $0 | 70,549 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | A Award deriv | 2026-02-09 | 2026-02-11 | 203,851 | — | $0 | 203,851 | SEC↗ |
| Sun Nelson | Chief Financial Officer | A Award deriv | 2026-02-09 | 2026-02-11 | 70,549 | — | $0 | 70,549 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-12-11 | 2025-12-12 | 7,000 | $14.49 | $101.4K | 1,551,613 | SEC↗ |
| Sun Nelson | Chief Financial Officer | P Buy | 2025-12-11 | 2025-12-12 | 3,000 | $14.40 | $43.2K | 108,484 | SEC↗ |
| Jones Bryan | Chief Operating Officer | M Exercise deriv | 2025-10-15 | 2025-10-16 | 1,250 | — | $0 | 40,052 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | M Exercise deriv | 2025-10-15 | 2025-10-16 | 1,229 | — | $0 | 40,566 | SEC↗ |
| Jones Bryan | Chief Operating Officer | M Exercise | 2025-10-15 | 2025-10-16 | 1,250 | $4.24 | $5.3K | 1,250 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | M Exercise | 2025-10-15 | 2025-10-16 | 1,229 | $4.24 | $5.2K | 1,544,613 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-09-15 | 2025-09-16 | 3,500 | $9.94 | $34.8K | 1,543,384 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-09-15 | 2025-09-16 | 6,500 | $9.51 | $61.8K | 1,539,884 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-09-12 | 2025-09-12 | 5,000 | $8.50 | $42.5K | 1,533,384 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-09-11 | 2025-09-12 | 6,000 | $7.82 | $46.9K | 1,528,384 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-09-10 | 2025-09-12 | 9,000 | $7.91 | $71.2K | 1,522,384 | SEC↗ |
| Sun Nelson | Chief Financial Officer | P Buy | 2025-09-09 | 2025-09-10 | 6,000 | $8.07 | $48.4K | 105,484 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | M Exercise deriv | 2025-08-28 | 2025-08-29 | 17,209 | — | $0 | 41,795 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | M Exercise | 2025-08-28 | 2025-08-29 | 17,209 | $4.24 | $73.0K | 1,513,384 | SEC↗ |
| Graf Susan E | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 30,508 | — | $0 | 30,508 | SEC↗ |
| Jones Bryan | Chief Operating Officer | A Award deriv | 2025-06-11 | 2025-06-13 | 122,033 | — | $0 | 122,033 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 30,508 | — | $0 | 30,508 | SEC↗ |
| Tong Victor Edward Jr | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 61,017 | — | $0 | 61,017 | SEC↗ |
| Sun Nelson | Chief Financial Officer | A Award deriv | 2025-06-11 | 2025-06-13 | 209,826 | — | $0 | 209,826 | SEC↗ |
| Jaiman Manasi | Chief Medical Officer | A Award deriv | 2025-06-11 | 2025-06-13 | 126,999 | — | $0 | 126,999 | SEC↗ |
| Chi Jeffrey | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 61,017 | — | $0 | 61,017 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | A Award deriv | 2025-06-11 | 2025-06-13 | 549,534 | — | $0 | 549,534 | SEC↗ |
| Chen Bihua | Other | C Conversion deriv | 2025-02-14 | 2025-02-19 | 6,780,810 | — | $0 | 0 | SEC↗ |
| Sun Nelson | Chief Financial Officer | C Conversion deriv | 2025-02-14 | 2025-02-19 | 59,332 | — | $0 | 0 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | C Conversion deriv | 2025-02-14 | 2025-02-19 | 350,002 | — | $0 | 0 | SEC↗ |
| Vickers Venture Fund VI Pte Lt | 10% Owner | C Conversion deriv | 2025-02-14 | 2025-02-19 | 3,503,919 | — | $0 | 0 | SEC↗ |
| Vickers Venture Fund VI Pte Lt | 10% Owner | C Conversion deriv | 2025-02-14 | 2025-02-19 | 13,875,429 | — | $0 | 0 | SEC↗ |
| Chi Jeffrey | Director | C Conversion deriv | 2025-02-14 | 2025-02-19 | 1,130,135 | — | $0 | 0 | SEC↗ |
| Decheng Capital Global Life Sc | 10% Owner | C Conversion deriv | 2025-02-14 | 2025-02-19 | 2,825,337 | — | $0 | 0 | SEC↗ |
| Decheng Capital Global Life Sc | 10% Owner | C Conversion deriv | 2025-02-14 | 2025-02-19 | 19,777,363 | — | $0 | 0 | SEC↗ |
| Chen Bihua | Other | C Conversion | 2025-02-14 | 2025-02-19 | 800,189 | — | $0 | 800,189 | SEC↗ |
| Chen Bihua | Other | P Buy | 2025-02-14 | 2025-02-19 | 187,500 | $16.00 | $3.00M | 987,689 | SEC↗ |
| Sun Nelson | Chief Financial Officer | C Conversion | 2025-02-14 | 2025-02-19 | 7,001 | — | $0 | 89,484 | SEC↗ |
| Sun Nelson | Chief Financial Officer | P Buy | 2025-02-14 | 2025-02-19 | 10,000 | $16.00 | $160.0K | 99,484 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | C Conversion | 2025-02-14 | 2025-02-19 | 41,303 | — | $0 | 1,479,633 | SEC↗ |
| Lee Tien-Li | Chief Executive Officer | P Buy | 2025-02-14 | 2025-02-19 | 16,542 | $16.00 | $264.7K | 1,496,175 | SEC↗ |
| Vickers Venture Fund VI Pte Lt | 10% Owner | C Conversion | 2025-02-14 | 2025-02-19 | 413,491 | — | $0 | 2,050,902 | SEC↗ |
| Vickers Venture Fund VI Pte Lt | 10% Owner | C Conversion | 2025-02-14 | 2025-02-19 | 1,637,411 | — | $0 | 1,637,411 | SEC↗ |
| Chi Jeffrey | Director | C Conversion | 2025-02-14 | 2025-02-19 | 133,364 | — | $0 | 133,364 | SEC↗ |
| Decheng Capital Global Life Sc | 10% Owner | C Conversion | 2025-02-14 | 2025-02-19 | 333,412 | — | $0 | 333,412 | SEC↗ |
| Decheng Capital Global Life Sc | 10% Owner | P Buy | 2025-02-14 | 2025-02-19 | 625,000 | $16.00 | $10.00M | 2,958,887 | SEC↗ |
| Decheng Capital Global Life Sc | 10% Owner | P Buy | 2025-02-14 | 2025-02-19 | 625,000 | $16.00 | $10.00M | 958,412 | SEC↗ |
| Decheng Capital Global Life Sc | 10% Owner | C Conversion | 2025-02-14 | 2025-02-19 | 2,333,887 | — | $0 | 2,333,887 | SEC↗ |